| Literature DB >> 28634383 |
Manit Srisurapanont1, Sirijit Suttajit2, Kanokkwan Eurviriyanukul2, Prirada Varnado2.
Abstract
This study aimed to determine: i) the correlation between objective and subjective cognition, ii) the correlates of objective and subjective cognition and iii) the predictors of discrepancy between objective and subjective cognition. Participants were non-elderly patients with major depressive disorder (MDD). We assessed subjective cognition using the Perceived Deficit Questionnaire for Depression (PDQ-D) and objective cognition using Face I and Face II tests of the Wechsler Memory Scale, 3rd edition and Digit Span and Matrix Reasoning tests of the Wechsler Intelligence Scale for Adults, 3rd edition. The discrepancy between objective and subjective cognition was estimated. Participants were 57 outpatients with MDD. PDQ-D scores were not correlated with composite neurocognitive test (NCT) z scores. Years of education significantly predicted composite NCT z scores, as did age. The 9-item Patient Health Questionnaire (PHQ-9) scores significantly predicted PDQ-D scores, as did antidepressant treatment. Age significantly predicted discrepancy scores, as did PHQ-9 scores. In conclusion, objective and subjective cognition in patients with MDD are not correlated. Age and education predict objective cognition. Depression. severity and antidepressant treatment predict subjective cognition. Age and depression severity may predict the discrepancy between objective and subjective cognition.Entities:
Mesh:
Year: 2017 PMID: 28634383 PMCID: PMC5478612 DOI: 10.1038/s41598-017-04353-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical and socio-demographic characteristics of 57 patients with major depressive disorder.
| Characteristics | Number |
|---|---|
| Female | 50 (87.7%) |
| Single: Married: Divorce/Widowed | 14 (24.6%): 32 (56.1%): 11 (19.3%) |
| First episode of MDD | 33 (57.9%) |
| Currently taking antidepressant(s) | 42 (73.3%) |
| Perceived disability | 41 (71.93%) |
| Being on benzodiazepines | 40 (70.2%) |
|
| |
| Age (Years) | 45.1 (12.8) |
| Years of education | 11.8 (5.2) |
| PHQ-9 total score | 13.3 (6.5) |
| CGI-S score | 3.2 (0.9) |
| PDQ-D score | |
| Retrospective + Prospective subscales | 12.5 (8.4) |
| Attention subscale | 7.5 (4.8) |
| Planning/organization subscale | 6.9 (4.3) |
| Total score | 26.9 (15.9) |
| Neurocognitive test score | |
| Face I + Face II | 65.1 (9.6) |
| Digit span | 15.7 (3.8) |
| Matrix reasoning | 12.4 (6.0) |
| Composite z score | 0.0 (0.8) |
| Discrepancy scoreb | 0.0 (1.2) |
a≥1 SDS subscale ≥ 5 points.
bComposite NCT z score subtracted by corresponding reversed PDQ-D z score.
CGI-S = Clinical Global Impression, Severity Scale; PDQ-D = Perceived Deficits Questionnaire for Depression; PHQ-9 = Patient Health Questionnaire.
Figure 1Correlation between composite z scores of four neurocognitive tests and perceived deficits questionnaire for depression scores (Pearson’s correlation coefficient r = −0.02, p = 0.91).
Socio-demographic and clinical characteristics correlated with objective cognitive function (z scores of 4 neurocognitive tests) and subjective cognitive function (PDQ-D score) in 57 patients with MDD.
| Pearson’s | Pearson’s | Pearson’s | |
|---|---|---|---|
| Age (years) | −0.49 ( | −0.11 ( | −0.38 ( |
| Education (years) | 0.56 ( | −0.11 ( | 0.25 ( |
| PHQ-9 Score | 0.25 ( | 0.50 ( | 0.55 ( |
aComposite NCT z score subtracted by corresponding reversed PDQ-D z score. PDQ-D = Perceived Deficits Questionnaire for Depression; PHQ-9 = Patient Health Questionnaire.
Differences of subjective cognitive function (PDQ-D score) and objective cognitive function (composite NCT z score) and between groups of major depressed patients.
| Composite NCT | Significant difference | PDQ-D score | Significant difference | Discrepancy scoreb | Significant difference | |
|---|---|---|---|---|---|---|
| Perceived disabilitya | ||||||
| No (N = 16) | −0.1 (0.8) |
| 20.4 (11.0) |
| −0.5 (1.0) |
|
| Yes (N = 41) | 0.0 (0.7) | 29.4 (16.9) | 0.2 (1.3) | |||
| Gender | ||||||
| Male (N = 7) | 0.4 (0.8) |
| 20.1 (9.5) |
| 0.0 (1.2) |
|
| Female (N = 50) | −0.1 (0.7) | 27.8 (16.5) | 0.0 (1.3) | |||
| Currently taking antidepressants | ||||||
| No (N = 15) | 0.2 (0.9) |
| 20.9 (14.6) |
| −0.1 (1.5) |
|
| Yes (N = 42) | -0.1 (0.7) | 29.0 (16.0) | 0.0 (1.2) | |||
| Currently taking benzodiazepines | ||||||
| No (N = 17) | 0.0 (0.7) |
| 24.7 (17.4) |
| −0.2 (1.6) |
|
| Yes (N = 40) | 0.0 (0.8) | 27.8 (15.4) | 0.1 (1.1) | |||
a≥1 SDS subscale ≥ 5 points. bComposite NCT z score subtracted by corresponding reversed PDQ-D z score.
Summary of multiple regression analyses for variables predicting PDQ-D total and composite z scores (N = 57).
| Variable | Composite NCT | PDQ-D score | Discrepancy scoreb | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
| SE |
|
| SE |
|
| SE |
| |
| Age (years) | −0.02 | 0.01 | −0.36** | −0.03 | 0.01 | −0.27* | |||
| Education (years) | 0.06 | 0.02 | 0.44** | 0.01 | 0.03 | 0.05 | |||
| PHQ-9 score | 0.01 | 0.01 | 0.06 | 1.33 | 0.28 | 0.54** | 0.09 | 0.02 | 0.48** |
| Perceived disabilitya | 5.18 | 4.01 | 0.15 | 0.02 | 0.32 | 0.01 | |||
| Currently taking antidepressants | 13.78 | 3.96 | 0.38** | ||||||
|
| 0.44, 0.40 | 0.40, 0.36 | 0.39, 0.34 | ||||||
|
| 13.68** | 11.69** | 8.20** | ||||||
*p < .05, **p < 0.01. a≥1 SDS subscale ≥ 5 points. bComposite NCT z score subtracted by corresponding reversed PDQ-D z score.